HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA Approval ANDA085022 (IVAX SUB TEVA PHARMS)
HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA Approval ANDA085022 (IVAX SUB TEVA PHARMS) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: HYDROCHLOROTHIAZIDE; Active ingredients: HYDROCHLOROTHIAZIDE; Application number: ANDA085022.
| Brand name | HYDROCHLOROTHIAZIDE |
|---|---|
| Active ingredients | HYDROCHLOROTHIAZIDE |
| Application number | ANDA085022 |
| Sponsor | IVAX SUB TEVA PHARMS |
| Dosage form | TABLET |
| Route | ORAL |
| Marketing status | Discontinued |
| Products in application | 1 |
| First approval date | 19770901 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →